Skip to main content
Get Alerts

Health Alerts

Your unified view of current, active outbreak investigations, elevated disease activity, and food and drug recalls -- reported directly by CDC, FDA, and USDA. Not CDC NORS, which is a historical archive compiled well after an investigation closes (see Data Explorer for the full historical record).

Download matching alerts as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Date range
Sort
Clear filters

Showing 121–140 of 441 alerts

Drug Recall 2026 record Source: FDA

Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2

Recall initiated
August 6, 2026
Reported by FDA
September 2, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15.

Recall initiated
August 6, 2026
Reported by FDA
September 2, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Recall initiated
August 6, 2026
Reported by FDA
September 2, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) 1000-count bottles (NDC 16729-456-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Recall initiated
August 6, 2026
Reported by FDA
September 2, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-455-17.

Recall initiated
August 6, 2026
Reported by FDA
September 2, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-454-15) b) 1000-count bottles (NDC 16729-454-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Recall initiated
August 6, 2026
Reported by FDA
September 2, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-453-17.

Recall initiated
August 6, 2026
Reported by FDA
September 2, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-452-17.

Recall initiated
August 6, 2026
Reported by FDA
September 2, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-451-15) and b) 1000-count bottles, (NDC 16729-451-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Recall initiated
August 6, 2026
Reported by FDA
September 2, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-17.

Recall initiated
August 6, 2026
Reported by FDA
September 2, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-449-17.

Recall initiated
August 6, 2026
Reported by FDA
September 2, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-448-17.

Recall initiated
August 6, 2026
Reported by FDA
September 2, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-447-17.

Recall initiated
August 6, 2026
Reported by FDA
September 2, 2026

View Details

FDA Food Recall Announcement - Pending Structured Confirmation 2026 record Source: FDA-ANNOUNCE

Sura Tanmen Hot and Sour Flavor Premium Japanese Noodles & Soup Base

Announced by FDA
August 6, 2026

Terminated

View FDA Announcement

Food Recall 2026 record Source: FDA

Marina Del Rey Foods inc.

Recall initiated
August 5, 2026
Reported by FDA
September 9, 2026

View Details

Food Recall 2026 record Source: FDA

Jaime's Foods ATX, LLC

Recall initiated
August 5, 2026
Reported by FDA
September 2, 2026

View Details

Food Recall 2026 record Source: FDA

Sirna and Sons Produce, Inc

Recall initiated
August 5, 2026
Reported by FDA
September 2, 2026

View Details

Food Recall 2026 record Source: FDA

Dairyland Produce, LLC

Recall initiated
August 5, 2026
Reported by FDA
August 26, 2026

View Details

Drug Recall 2026 record Source: FDA

Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3.

Recall initiated
August 5, 2026
Reported by FDA
August 12, 2026

View Details

Data last updated:

Investigations and recalls may be ongoing; status, case counts, and guidance are updated by the source agency as events continue. Read the full medical disclaimer.

Explore more